Adrian XH
Tesofensine has one large published obesity trial, and the journal that published it later put an Expression of Concern on the paper. FDA hasn’t approved the drug. In December 2025 it said compounded drugs made from tesofensine are ineligible for the section 503A exemptions. This page covers what the trial found, where tesofensine stands with …
Peptides sold online as “research chemicals” are not approved for human use, and what is in the vial is often unknown. The best-documented test, from 2024, found vials sold as semaglutide that were mostly not semaglutide. This page covers what testing, FDA and drug labels show. It does not give doses or injection steps. What …
Tesofensine is not a peptide. It’s a small-molecule drug that has never been approved by the FDA. The one published phase 2 trial showed real weight loss, but the journal that printed it later flagged concerns about how the trial was run. This page covers what that trial found, what the Lancet said about it, …
Research use only. Nothing on this page is medical advice, and Vilon isn’t approved for human use. Vilon is the dipeptide Lys-Glu (KE) from Vladimir Khavinson’s group. No independent trial has tested it in people, and its cancer record in animals is mixed: it lowered bladder tumors in rats but raised mammary cancer in HER-2/neu …
Most cistanche supplements are weak garbage because buyers cannot find standardized extracts. The market floods raw stem powder instead of active phenylethanoid glycosides. Most guides confuse raw herb with real compounds because they never mention that echinacoside percentage matters more than capsule count. This article ranks supplements by echinacoside content and human evidence so you …
PEG-MGF is a pegylated version of mechano growth factor (MGF), a splice variant of IGF-1. No study of PEG-MGF itself has been published. The best-known mouse result came from a gene plasmid. FDA flags an immunogenicity risk for compounded PEG-MGF. WADA bans MGFs at all times. This page covers what MGF is, what the animal …